Molecular subtypes of pancreatic cancer: A proteomics approach

Ravi Thakur, Pankaj K. Singh

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Through molecular subtyping, therapeutic vulnerabilities can be exploited for developing personalized medicine. The real utility of molecular subtyping lies in the clinical translation for disease characterization. Proteomic methods with defined marker sets hold great promise for improving therapy outcomes by improving the speed of predictions for devising treatment strategies.

Original languageEnglish (US)
Pages (from-to)3272-3274
Number of pages3
JournalClinical Cancer Research
Volume27
Issue number12
DOIs
StatePublished - Jun 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Molecular subtypes of pancreatic cancer: A proteomics approach'. Together they form a unique fingerprint.

Cite this